Trade Summary

Yesterday, Foresite Capital Management V, LLC, serving as 10% owner Owner at Latigo Biotherapeutics, Inc. (LTGO), purchased 140,000 shares at $18.00 per share, for a total transaction value of $2,520,000.00. Following this transaction, Foresite Capital Management V, LLC now holds 2,008,024 shares of LTGO.

This purchase represents a 7.49% increase in Foresite Capital Management V, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, August 10, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, August 11, 2026 (accepted Aug 10, 8:21 PM ET), 1 day after the trade was made.